MedPath

Alanyl glutamine

Generic Name
Alanyl glutamine
Drug Type
Small Molecule
Chemical Formula
C8H15N3O4
CAS Number
39537-23-0
Unique Ingredient Identifier
U5JDO2770Z
Background

Alanyl Glutamine is under investigation in clinical trial NCT00338221 (Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition).

Indication

Not Available

Associated Therapies
Dietary and Nutritional Therapies
Clinical Trials
Related News

Glutamine Effects in Burn Patients

Phase 2
Conditions
Drug Effect
Interventions
Drug: normal Saline
First Posted Date
2021-12-01
Last Posted Date
2021-12-01
Lead Sponsor
Menoufia University
Target Recruit Count
60
Registration Number
NCT05140772
Locations
🇪🇬

Ashraf Magdy Eskandr, Shibeen Elkoom, Egypt

Role of Glutamine as Myocardial Protector in Elective On-Pump CABG Surgery With Low EF

Phase 3
Completed
Conditions
Coronary Artery Bypass
Cardiopulmonary Bypass
Coronary Artery Disease
Interventions
Drug: Placebo
First Posted Date
2020-09-23
Last Posted Date
2023-11-13
Lead Sponsor
National Cardiovascular Center Harapan Kita Hospital Indonesia
Target Recruit Count
60
Registration Number
NCT04560309
Locations
🇮🇩

National Cardiovascular Center Harapan Kita Hospital Indonesia, Jakarta, Indonesia

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)

Phase 2
Recruiting
Conditions
Clostridium Difficile Infection
Clostridium Difficile Diarrhea
Clostridia Difficile Colitis
Clostridioides Difficile Infection
Interventions
First Posted Date
2020-03-12
Last Posted Date
2024-10-26
Lead Sponsor
University of Virginia
Target Recruit Count
260
Registration Number
NCT04305769
Locations
🇺🇸

Carilion Clinic, Roanoke, Virginia, United States

🇺🇸

UVA Health Systems, Charlottesville, Virginia, United States

Optimized Therapy in Severe Traumatic Brain Injured Patients

Phase 4
Completed
Conditions
Coma
Traumatic Brain Injury
Interventions
First Posted Date
2014-05-05
Last Posted Date
2014-05-06
Lead Sponsor
University of Zurich
Target Recruit Count
12
Registration Number
NCT02130674
Locations
🇨🇭

University Hospital Zurich, Zurich, Switzerland

Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection

Phase 2
Terminated
Conditions
Clostridium Difficile Infection
Interventions
First Posted Date
2014-02-03
Last Posted Date
2022-06-07
Lead Sponsor
University of Virginia
Target Recruit Count
7
Registration Number
NCT02053350
Locations
🇺🇸

University of Virginia Health System, Charlottesville, Virginia, United States

Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition

Phase 3
Withdrawn
Conditions
Diarrhea, Malnutrition
First Posted Date
2006-06-20
Last Posted Date
2008-10-28
Lead Sponsor
University of Virginia
Target Recruit Count
108
Registration Number
NCT00338221

HIAS II - Study of Nutritional Supplementation in Hospitalized Children With Persistent Diarrhea or Malnutrition

Phase 3
Withdrawn
Conditions
Diarrhea, Malnutrition
Other Nutritional Deficiencies
First Posted Date
2005-08-23
Last Posted Date
2008-10-28
Lead Sponsor
University of Virginia
Target Recruit Count
108
Registration Number
NCT00133562
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy